Suboptimal guideline-directed medical therapy and prognosis in patients with heart failure and reduced ejection fraction: The SMYRNA Study

dc.contributor.authorKocabas, U.
dc.contributor.authorErgin, I.
dc.contributor.authorKivrak, T.
dc.contributor.authorOztekin, G. M. Yilmaz
dc.contributor.authorTanik, V. O.
dc.contributor.authorOzdemir, I. H.
dc.contributor.authorYeni, M.
dc.date.accessioned2026-08-12T18:12:59Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.descriptionAnnual Meeting of the European-Society-of-Cardiology (ESC) -- AUG 25-28, 2023 -- Amsterdam, NETHERLANDS
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Soc Cardiol
dc.identifier.issn0195-668X
dc.identifier.issn1522-9645
dc.identifier.urihttps://hdl.handle.net/11508/64151
dc.identifier.volume44
dc.identifier.wosWOS:001115619401288
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofEuropean Heart Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleSuboptimal guideline-directed medical therapy and prognosis in patients with heart failure and reduced ejection fraction: The SMYRNA Study
dc.typeConference Object

Dosyalar